Stay updated on Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Sign up to get notified when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.

Latest updates to the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page
- Check2 days agoChange DetectedA sitewide NIH notice was added about website updates and the transition from “Artificial Intelligence” to “Super Intelligence.” The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now renders a 403 Forbidden error page instead of the study record. The new content shows a minimal header and a Home link, indicating the study details at this URL are inaccessible.SummaryDifference18%

- Check36 days agoChange DetectedThe page now displays a newer revision identifier, changing from v3.6.6 to v3.7.0. This reflects a backend/template update and does not modify the study details or content shown on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedThe study record now displays a new NIH funding line, '2018 ( U.S. NIH Grant/Contract )', clarifying the source of support for the CARACAS trial.SummaryDifference0.1%

Stay in the know with updates to Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.